|
|
|
|
| Though the number of CDMOs with mRNA/RNA capabilities is increasing, many of these are better equipped for large-scale, linear mRNA development. Don't miss Advancing RNA Live on January 21st as our panel shares how mRNA and next-gen RNA modality companies need to be evaluating CDMO platforms. Attendance is free thanks to the support of Cytiva. |
|
|
|
|
By AR Welch, Editorial & Community Director, Advancing RNA | As the Charles Dickens fans among us already know, there is still one pretty important “ghost” that has yet to be channeled on this “hallowed” page, and that’s the “Ghost of mRNA/RNA Innovations Yet To Come.” (Yes. That’s a thing.) Here, I share several future-facing “visions” from the conversations I had with five RNA leaders. |
|
|
|
By Kishore Hotha, Ph.D., Dr. Hotha’s Life Sciences LLC | Developing a practical chemistry, manufacturing, and controls (CMC) strategy for oligonucleotides and peptides demands a shift in approach in terms of the way you collaborate with your CDMO. |
|
|
|
Three LNP experts from Sanofi, Hopewell Therapeutics, and BioNTech collectively discuss how far we’ve come in understanding the structure of our LNPs while also shedding light on the variables that have the greatest potential of causing shifts in our products’ structure/function. |
|
|
|
By Antony Hitchcock, principal and owner, AGH Bioconsulting | The demand for plasmid DNA products is intrinsically linked to unique market conditions and funding environments. Here's what's driving them. |
|
|
|
| Demystifying CRISPR gRNA Chemical Modifications | Article | By R. Roberts, Ph.D., K. Holden, Ph.D., and A. Zepeda, Synthego Corporation | Chemical modifications on CRISPR gRNAs enhance stability, editing efficiency, and reduce immune responses, enabling in vivo applications and clinical success. |
|
|
|
| Empowering A New Era Of Patient-Centric Medicines | Podcast | Nanoform | Discover the challenges pharma companies are facing as they switch focus as well as the actions and technologies companies are implementing to help achieve a brighter future for patients. |
|
|
|
| How To Plan For Trouble-Free Filter Validation | Webinar | Cytiva | Watch to learn when filter validation should be performed, what is required from an end user and laboratory testing perspective, and how to achieve first-time success for various drug products. |
|
|
|
.png){kind=logo}
